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ABSTRACT 
Dendritic molecules are highly ordered, regularly branched, and monodisperse macromolecules. Due to their unique and well-defined 
macromolecular structure they are attractive scaffolds for a variety of high-end applications and constitute a fascinating nanoscale 
toolkit. They are of great interest to both, nano and polymer science, as building blocks due to their unique macromolecular properties. 
In recent years, research in the field of dendritic chemistry has experienced an exponential development in academic and technological 
areas and such macromolecular structures have also been extensively explored in materials science, specifically in biomedical areas. The 
unique advantages offered by dendritic architectures over conventional macromolecules and polymers are the presence of multiple 
functional groups and their amenability to further chemical modification, extremely low molecular weight dispersity, low solution 
viscosity, reduced molecular entanglement, and nanoscopic size within the range of 1 to 10 nm.  
The objective of this review is to show the advantage of the dendritic structures, their main properties, and to reflect on their 
development and use in various science applications. Particular emphasis will be place on biomedical and nanomedicine applications. 
Therefore, key examples will be discussed to illustrate the main principles involved in dendritic chemistry, and the applications of the 
dendritic structures at the interfaces between chemistry, biology and biomedicine. 
Keywords: dendrimer, hyperbranched polymer, functional polymer, biomedicine, dendritic effect. 
MATERIALES HIPERRAMIFICADOS E HIPERFUNCIONALIZADOS DERIVADOS DE LA 
QUÍMICA DENDRÍTICA  
RESUMEN 
Las moléculas dendríticas son altamente ordenadas, regularmente ramificadas y monodispersas. Debido a su estructura macromolecular 
única y bien definida, ellas constituyen una atractiva plataforma hacia una gran variedad de aplicaciones; siendo además, una fascinante 
herramienta para la construcción de materiales a escala nanométrica. Por lo tanto, debido a sus destacadas propiedades 
macromoleculares hay un gran interés en el uso de las mismas como unidades de construcción, tanto para la ciencia de polímeros como 
para la nanociencia. En los últimos años la investigación en el campo de la química dendrítica ha experimentado un desarrollo 
exponencial, tanto en el área académica como en la tecnológica. Por lo tanto, tales estructuras macromoleculares han sido 
extensivamente exploradas en la ciencia de los materiales, mas específicamente en áreas biomédicas. Las arquitecturas dendríticas 
ofrecen ventajas únicas con respecto a otras macromoléculas y polímeros convencionales, como  son la presencia de múltiples grupos 
funcionales y su versatilidad para sufrir posteriores modificaciones químicas, baja dispersidad en pesos moleculares, baja viscosidad, 
reducido enredamiento molecular y tamaño nanoscópico dentro del rango de 1 a 10 nanometros. El objetivo de esta presentación es 
mostrar las ventajas de las estructuras dendríticas, sus principales propiedades,  desarrollo y uso en varias ciencias aplicadas. 
Particularmente, se hará énfasis en aplicaciones biomédicas y en nanomedicina. Por lo tanto, se discutirán ejemplos claves que ilustrarán 
los principios más importantes en los cuales se basa la química dendrítica, y las principales aplicaciones de las estructuras dendríticas en 
la interface entre la química, la biología y la biomedicina. 
Palabras claves: Synthesis, Characterization, Nanoparticles, Cobalt ferrite, Magnetic properties.  
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1. INTRODUCTION 
The three traditional macromolecular architectural 
classes (i.e., linear, cross-linked, and branched) are 
widely recognized to generate rather polydisperse 
products of different molecular weights. In contrast, 
a new route to create very well-defined, 
monodisperse, stable molecular level nanostructures 
is being studied based on the “dendritic state” 
architecture.  
Dendrimers are highly defined macromolecules, 
characterized by their precisely branched tree-like 
structures with a combination of high end-group 
functionality with globular shape and compact 
molecular structure. A typical dendrimer is 
composed of a focal core from which several 
repetitive units of building blocks are radially 
arranged forming the branches. Such a modular 
arrangement of branches provides two structural 
parameters to a dendritic molecule: (a) with 
increasing number of generation, the molecule takes 
on a spherical shape due to symmetrical crowding of 
the branching fragments over the periphery of the 
molecule, and (b) the multiple surface functional 
groups are amenable for wide range of chemical 
modification. Another important feature of a 
dendritic architecture is the supramolecular voids 
located within the structure due to their core-shell 
character.[1, 2] 
The stepwise synthesis of dendrimers affords 
molecules with a highly regular branching pattern, a 
unique molecular weight or a low dispersity index, 
and a well-defined number of peripheral groups. 
They possess three key architectural features, 
namely (1) an initiator core (or focal point), (2) 
interior branching units (branch cells), and (3) 
mathematically defined numbers of functional 
surface groups, as a function of generation (G) 
level.[3-5] Studies on dendritic polymers are based 
on their “dendritic state” architecture and comprise 
sub-classes such as dendrimers, dendrons, 
hyperbranched polymers, and dendrigraft polymers 
(Figure 1).  
The convergence of architecturally driven “dendritic 
effects” together with the ability to control the 
nanoscale size, shape, and chemical functionality of 
these dendritic constructs have led to many new 
unprecedented properties. The unique advantages 
offered by a dendritic molecule over conventional 
macromolecules and polymers have spurred 
extensive interest within the scientific community to 
explore their potential applications in areas such as 
medicine, biology, catalysis, optics, electronics, 
surface science, and many other fields. Recently, 
several review articles regarding dendritic polymers 
applications in various fields have been 
published.[6-9]  In this article, we will focus on their 
synthetic methodologies as well as on their potential 
biomedical applications. 
 
Figure 1. Subclasses given at the dendritic state. 
Modified with permission from [2]. Copyright 2004, John 
Wiley and Sons. 
1.1 Synthesis of dendritic polymers 
Since the seminal work in the dendritic field, 
published about three decades ago,[10-13] a large 
number of dendrimer structures have been 
developed. The development of novel synthetic 
methodologies and the screening of potential uses 
have become a subject of intense interdisciplinary 
research efforts, bringing together scientists from 
entirely different areas. The structural advantages of 
the dendrimers have established them as valuable 
model compounds to study fundamental 
electrochemical, photophysical, and supramolecular 
properties. 
Synthetically, dendrimers can be prepared by either 
a divergent or convergent approach, each of which 
have their own synthetic advantages and limitations. 
In the divergent method, as pioneered by Tomalia et 
al.,[14] dendrimers are synthesized radially from a 
central core molecule (Figure 2.2, top panel). The 
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dendrimer synthesis takes place through a stepwise 
layer-by-layer modification that starts from the focal 
core and builds up the molecule towards the 
periphery using two basic chemical manoeuvrings: 
firstly, the building blocks are coupled to the core, 
and secondly, the end-group functionalities of the 
attached building block are modified for further 
growth. The divergent approach is strategically 
straightforward and controllable. Nevertheless, 
synthesis of high-generation of dendrimers is often 
defected due to steric effects and purification of the 
final product is usually difficult.  
 
 
Figure 2. Divergent (A-top panel) and convergent (B-bottom panel) synthesis of dendrimers.[15] 
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Figure 3. Original repetitive synthesis using a divergent iterative methodology developed by Vögtle et al.  
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Vögtle and coworkers reported the first preparation 
of simple dendritic structures via a divergent 
iterative methodology (Figure 3). They described 
this cascade synthesis as “reaction sequences” that 
can be carried out repetitively. Interesting examples 
about divergent methodology are the reports from 
Newkome et al. [16] and Tomalia et al. [17] 
published in 1985, who described different 
divergent routes to 13 C-branching arborols 
(Figure 4) and 12 N-branching dendrimers, 
respectively. 
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 Figure 4. Synthesis of dendrimers using divergent routes to 1--3 C-branching arborols developed by Newkome et al.[16]  
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Figure 5. Synthesis of poly(arylmethyl) dendrimers using convergent methodology.[19] 
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On the other hand, the convergent method reported 
by Fréchet and Hawker involves the preferential 
construction of branched subunits (dendrons), which 
are then attached to a multi-functional core (Figure 
2.2, bottom panel).[18] The convergent approach 
overcomes some of the problems associated with the 
divergent approach, mainly those associated with 
purification due to a difference of molecular weight 
between the preformed branches and the core 
molecule. The major disadvantage of dendrimer 
synthesis by this method is again the steric 
crowding. As the dendrimer generation increases, 
the reactive groups are buried at the focal point of 
the dendrons, and the attachment of the preformed 
units to the core-fragment becomes increasingly 
difficult. 
Rajca [19] reported in 1991 an elegant route for the 
construction of dendritic thiphenylmethyl 
polyradicals and polyanions using the convergent 
methodology (Figure 5). The largest molecule yet 
reported in this series had an extended diameter of 3 
nm and a molecular mass of approximately 2800 g 
mol-1. 
Fréchet et al. described the synthesis of dendrimers 
via a “double stage convergent growth method as 
described in Figure 6 [20]. Essentially, the approach 
leads to dendrimers comprised of different 
monomers at different generations. 
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Figure 6. Preparation of dendrimers via a double stage convergent growth method [20]. 
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The use of the convergent and divergent approaches 
has led to the synthesis of over one hundred 
compositionally different dendrimer families and, in 
addition, more than 1000 differentiated chemical 
surface modifications.[12, 21, 22] However, even 
today complex polymer structures, including 
dendritic materials, have struggled to be 
commercialized on a large scale by industries. The 
main reason is that they are, in most cases, difficult 
to synthesize, leading to extremely high production 
costs. Traditional synthetic proceadures involve 
repetitive stepwise growth and 
deprotection/activation protocols with careful 
purification procedures between each generation.[4] 
Typically, the synthesis of G4 dendrimers requires a 
minimum of 8 reaction steps, not including the 
monomer synthesis. In such way, their synthesis is 
time-consuming and generates significant quantities 
of waste. Simplifying the synthetic preparation of 
dendrimers, therefore, has been a major challenge, 
and a continuous improvement of synthetic 
methodologies for dendritic structures is a crucial 
step towards their commercial success.  Recent 
synthetic advances in the field of organic and 
polymer chemistry have provided researchers with 
new tools to prepare these intricate structures more 
efficiently. As result, controlled synthesis of 
hyperbranched polymers[23, 24], as well as novel 
“dendronization” techniques[25-35] have emerged 
as alternative to the conventional dendrimer 
syntheses described above. 
Instead of the step-wise and tedious procedures used 
for synthesis of perfect dendrimers, hyperbranched 
polymers are prepared in a one-step synthetic 
strategy. Due to their similar physicochemical 
properties like low viscosity, good solubility, and 
multi-functionality, dendrimers and hyperbranched 
polymers are used indistinctly in several fields of 
application. Hyperbranched polymers exhibit a 
similar tree-like like structure which is more flexible 
than dendrimers due to lower degree of branching. 
The common polymerization reactions to assess 
hyperbranched polymers are classified into three 
categories: step-growth polycondensation of ABx 
monomers, self-condensing vinyl polymerization of 
AB monomers, and multibranching ring-opening 
polymerization of latent ABx monomers. In 
1992,[36] Suzuki et al. reported palladium 
catalyzed, ring-opening polymerization (ROP) of a 
cyclic carbamate. The polymerization was proposed 
to be an in situ multibranching process. The 
molecular weight of the polymers could be 
controlled by the initiator/monomer ratio.  
Toward the synthesis of hyperbranched polymers 
for biomedical applications, the first hyperbranched 
polymer obtained via ROP was poly(ethylene imine) 
(PEI). The recent focus by Haag et al. on the 
development of hyperbranched polyglycerols (PG) 
have yielded a family of dendritic compounds with a 
wide range of biomedical applications.[37] 
Hyperbranched PG is typically synthesized from the 
commercially available and highly reactive hydroxy 
epoxide, glycidol, representing a latent AB2 
monomer by utilizing the ring-opening 
multibranching polymerization (ROMBP) process 
(Figure 7).[38, 39]  
Dendronization techniques, on the other hand, have 
shown a great versatility for the preparation of 
dendronized materials. The structural information 
programmed into the dendritic architecture can be 
used in the dendronization process to generate 
nanostructures with specific tailored properties.[33] 
The use of different dendrons, with diverse chemical 
structure and size, has been extensively explore to 
functionalize diverse substrates like linear polymers, 
and plane and curved inorganic surfaces (Figure 8). 
Dendronized polymers offer a new kind of 
molecules that can have rich and complex 
equilibrium and dynamic behavior with significant 
applications in nanotechnology. The molecular 
architecture of dendronized polymers can be turned 
on to obtain nanoscale objects with tailored 
properties. Functionality and branching are 
important aspects to be considered for 
changing/modifying the properties of base linear 
polymers through a careful selection of the chemical 
structure and polarity of the branched units. 
On analysis of these ubiquitous dendritic patterns it 
is evident that these highly branched architectures 
offer unique interfacial and functional performance 
advantages. Based on the rapid advances in this area 
over their history, the quest for practical 
applications for dendrimers is on the rise. At 
present, there are more than 10000 scientific reports, 
increasing by more than 1000 per year, as well as 
about 150 patents dealing with dendritic 
structures.[26, 46-48] 
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Figure 7. Mechanism of anionic polymerization of glycidol to form well-defined hyperbranched polyglycerols by slow 
monomer addition.[37] 
 
Figure 8. Dendronization process of different substrates. 
 
2. BIOMEDICAL APPLICATIONS OF 
DENDRITIC POLYMERS 
Based on the rapid advances in the dendritic 
chemistry over the past 20 years, the quest for 
practical applications for dendrimers is becoming 
increasingly intense. Owing to the tedious stepwise 
synthetic construction of dendrimers, future 
applications will have to be highly specific and a 
precise nanoengineered structure will be a crucial 
prerequisite for the targeted application. Bulk 
applications, for example, as processing additives, 
specialty coatings, or as rheology modifiers will be 
realized with random cascade-branched 
hyperbranched materials, which are structurally less 
defined but can be prepared in a single 
polymerization step. Dendronization methology 
used onto classic linear polymers or on small 
organic molecules, is other easy strategy that allow 
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obtaining dendritic effect in a rapid manner [27, 29]. 
Therefore, it allows increasing the scale of the 
synthesis of final materials.  
Considering the amount of reports published in the 
last decade, it is apparently clear that a substantial 
part of dendrimer research has been focused towards 
the utilization of these molecules for the 
development of biomedical tools and related 
technologies. Such a huge surge in engaging 
dendrimers in biomedicine stems from several 
unparallel biological properties of dendrimers not 
offered by conventional polymers or self-assembled 
nanostructures like liposome or micelles. Owing to 
the special chemical, physical, and biological 
features of dendrimers, and their application 
mechanism as described above, an extensive effort 
has been pushed forward to utilize these special 
molecules in therapeutic and diagnostic purposes for 
the treatment of several diseases. In addition, novel 
approaches have been explored where the dendritic 
scaffold itself can be utilized as a therapeutic 
agent.[1] 
 
2.1 Dendrimers for drug delivery 
A comparison of the features of dendrimers with 
those of linear polymers shows that the dendritic 
architecture can provide several advantages for drug 
delivery applications. In dendrimer-based drug 
delivery systems, a drug is either non-covalently 
encapsulated in the interior of the dendrimer or 
covalently conjugated to form a macromolecular 
prodrug. Initial studies of dendrimers as potential 
delivery systems focused on their use as 
unimolecular micelles and dendritic boxes for the 
non-covalent encapsulation of bioactive agents.[49] 
For example, in early studies, DNA was complexed 
with PAMAM dendrimers for gene delivery 
applications [50] and hydrophobic drugs and dye 
molecules were incorporated into various dendritic 
cores.[51, 52] In addition, the controlled 
multivalency of dendrimers can be used to attach 
several drug molecules, targeting groups and 
solubilizing groups to the periphery of the 
dendrimers in a well-defined manner as described in 
Figure 9.  
 
 
Figure 9. Dendritic polymers as drug delivery scaffolds: (a) non-covalent encapsulation, (b) multifunctional dendritic 
polymer. Copyright 2012, Elsevier. [53] 
 
The non-covalent approach has paved the way to the 
use of core-shell dendritic motifs prepared by the 
covalent modification of dendritic macromolecules 
with an appropriate shell. This results in stable 
micelle-type structures that are suitable for non-
covalent encapsulation of guest molecules. 
Dendritic polymers with their regular and well-
defined unimolecular architecture can be chemically 
modified either at the core (to increase 
hydrophobicity) or at the shell (to increase 
hydrophilicity) thereby tailoring the solubility 
profile of such nanotransport systems. Based on this 
concept, a simple and general method for the 
generation of core-shell type architectures from 
readily accessible hyperbranched polymers was 
extensively explored by Haag et al.[54-58] 
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Universal nanotransporters as well as several pH 
sensitive nanocarriers have been prepared by 
attaching pH sensitive shells through acetal or imine 
bonds to commercially available dendritic core 
structures, such as polyglycerol and 
polyethyleneimine. Various guest molecules, such 
as polar dyes, oligonucleotides, and anticancer drugs 
have been encapsulated inside these dendritic core-
shell architectures and transported to intracellular 
compartments. 
The covalent approach, on the other hand, allows to 
better control the drug loading by varying the 
generation number of the dendrimer, and the release 
kinetics by incorporating degradable linkages 
between the drug and the dendritic polymer. As 
example, Duncan and coworkers pioneered this field 
by preparing conjugates of PAMAM dendrimers 
with cisplatin, a potent anticancer drug with 
nonspecific toxicity and poor water solubility.[59] 
The conjugates showed increased solubility, 
decreased systemic toxicity, and selective 
accumulation in solid tumors. Several other 
examples have been described by Haag and others 
which are extensively described in literature.[60-63]  
The unique features from the dendritic architecture 
have the additional advantage that they lead to 
particular pharmacological profiles. For instance, 
the low polydispersity of dendrimers should provide 
reproducible pharmacokinetic behavior in contrast 
to that of some linear polymers containing fractions 
with vastly different molecular weight within a 
given sample. Furthermore, the more globular shape 
of dendrimers, as opposed to the random coil 
structure of most linear polymers, could affect their 
biological properties, leading to the discovery of 
interesting effects related to macromolecular 
architecture. Their structural advantages allow a 
rapid cellular passage, higher cell-membrane 
permeability, reduced macrophage activation, 
controllable toxicity, and amplification of molecular 
effects or the creation of extremely high local 
concentrations of drugs, molecular labels, or probe 
moieties in a specific sites, as example a tumor or 
malign tissues. 
2.2 Dendrimers for diagnosis (Imaging) 
Dendritic polymeric architectures have been widely 
used for in vivo imaging purposes in versatile 
research approaches. A broad variety of probes have 
been synthesized for magnetic resonance imaging 
(MRI), X-ray imaging, ultrasound, radiodiagnostics, 
and optical imaging, as well as multimodal 
techniques combining these diagnostic 
techniques.[64] 
There are two major design principles that combine 
dendritic structures and diagnostic entities. The first 
is that dendritic polymers are covalently linked to 
one or multitude of signaling molecules on their 
periphery, thereby introducing the physical 
detectability into a polymeric or dendritic conjugate. 
For instance, application for the less sensitive MRI 
and X-ray techniques require doses of contrast 
agents, which are achieved only through 
multimerization of the signaling molecules, such as 
gadolinium complexes or tri-iodinated 
benzenes.[63] The molecular imaging techniques of 
radio imaging and fluorescence have high 
instrumental sensitivity requiring not more than one 
signaling molecule, e.g. a chelator for 99mTc, 111In 
(Single Photon Emission Computed Tomography, 
SPECT), 64Cu, 68Ga (Positron emission tomography, 
PET), or a fluorescent dye, in a given 
macromolecular of dendritic targeting entity.[65] 
The other design is a complementary class of 
imaging probes that is based on inorganic 
nanoparticles being combined with dendritic 
structures which impart stability and 
biocompatibility to the particles and provide 
multivalent surface architecture. The most studied 
particles have been semiconductor quantum dots for 
fluorescence detection,[66] gold nanoparticles and 
nanorods suited for optoacoustic/photoacoustic 
detection,[67] and iron oxide particles for MRI.[68]  
Both design approaches additionally incorporate a 
multitude of targeting moieties in order to achieve 
multivalent target binding properties, for example, 
by using low molecular weight peptides, glycans, or 
other biological or synthetic targeting moieties. 
Furthermore, a combination of different signaling 
units permits multimodality imaging applications, 
by e.g. doping a quantum dot (QD) surface with a 
radioisotope or an iron oxide particle with a 
fluorescent dye.[69]  
As example, dendritic polymers have been 
extensively studied as MRI contrast agents. The 
main properties of the dendritic structures for their 
application in this area of the biomedicine are the 
incorporation of many paramagnetic centers which 
can be used due to their appropriate 
pharmacokinetic properties in combination with 
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shortening of proton relaxation times and signal 
intensification.[70-72] In addition, the 
multifunctional nature of dendritic polymers 
provides an ideal platform to realize agents with 
multimodal imaging capability combined with 
active targeting.[70,73]  Pioneering work by Wiener 
et al.[74] resulted in the development of folate-
conjugated PAMAM dendrimers capable of both 
MRI and fluorescence imaging.[75] 
2.3 Dendrimers for therapy 
A recent increasing interest has been devoted to 
novel approaches where the dendritic scaffold itself 
can be utilized as a therapeutic agent. The first of 
this kind of dendrimers that have already entered 
into phase II human clinical trials are the anionic 
functionalized poly(L-lysine) dendrimers, that are 
called Vivagel and were developed by Starpharma 
(Melbourne, Australia). Vivagel is the first 
dendrimer-based product to have received Fast 
Track Status from the FDA under an investigational 
new drug application for the prevention of genital 
herpes. A G4 poly(L-lysine)-based dendrimer with 
naphthalene disulfonic acid surface groups (i.e. 
SPL7013) is the active ingredient in Vivagel1. 
Another innovative approach is the so-called “self-
immolative dendrimers” designed by Shabat et al. 
This innovative prodrug concept can open the way 
to stimuli-responsive dendrimers which release the 
drug upon activation by specific molecular markers 
over-expressed in cancer tissues.[76]  
Dendritic polyglycerol (PG) sulfates hold the 
promise for treatment of chronic inflammation 
related diseases. Such polymers have been initially 
reported as new heparin analogues.[77] They were 
found to prolong the time of activated partial 
thromboplastin as well as thrombin and to inhibit 
both the classical and alternative complement 
activation more effectively than heparin itself. The 
biocompatible and well-tolerated PG sulfate acts as 
multivalent selecting ligand mimetics and efficiently 
blocks leukocyte migration. L- and P-selectin 
binding to immobilized ligands was drastically 
reduced by the PG sulfates in vitro and gave IC50 
values in the low nanomolar range.[78] In an in vivo 
model it was observed that the administration of 
dendritic PG sulfates in a contact dermatitis model 
dampened leukocyte extravasation as effectively as 
did glucocorticoids, and edema formation was 
significantly reduced. In order to investigate 
whether dPGS addresse inflamed tissue, imaging 
studies were performed using dPGS labeled with the 
near infrared (NIR) dye indocyanine green (ICG) in 
an animal model of rheumatoid arthritis. The in vivo 
accumulation results demonstrated a fast and 
selective uptake which enabled the differentiation of 
disease scores and allowed identification of joints 
with early signs of inflammation. Localization in 
tissues using fluorescence histology showed that the 
conjugates are mainly deposited in the inflammatory 
infiltrate in the synovial membrane, whereas non-
sulfated control was not detected in association with 
disease (Figure 10). [79, 80] 
3. CONCLUSIONS 
It is known that dendrimers have unique qualities, 
making them ideal candidates as materials in a 
number of nanoscale and high-value added 
applications. The high level of control over their 
architecture, size, shape, branching length, and 
density, and their surface functionality, makes these 
compounds ideal carriers in biomedical applications 
such as drug delivery, gene transfection and 
imaging. Furthermore, the high density of surface 
groups allows attachment of targeting groups as well 
as groups that modify the solution behavior or 
toxicity of dendrimers. Unfortunaly, the 
commercialization of monodisperse dendritic 
structures has been restricted by their tedious and 
costly synthesis. However, progress on the study of 
different synthetic methodologies has been getting 
on the nanometer scale structures that preserve the 
dendritic effects, which have shown interesting 
applications in several areas. Clear examples of this, 
are the hyperbranched polymers, dendronized 
nanoparticles and polymers, and materials obtained 
from self-assembly of dendrons. Since most 
applications rely mainly on the high end group 
functionality of dendrimers and not on their unique 
structural perfection, randomly branched dendritic 
materials represent a promising alternative. 
Although it has been demonstrated that the 
structural perfection of dendrimers is an important 
prerequisite for magnetic resonance imaging, a 
monodisperse structure may not be required for 
numerous other applications. 
This review of dendritic materials illustrates that one 
of the main applications of dendrimers is clearly 
defined to nanomedicine and shows the potential of 
this new “fourth architectural class of polymers” and 
substantiates the high optimism for the future of 
dendrimers in this important fields. However, higher 
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functionality and regularly branching are important 
aspects to be considered for changing/modifying the 
properties of base materials to give them specifically 
properties derived of the dendritic chemistry and it 
is achieved through careful selection of a synthetic 
methodology to obtain dendritic properties in a more 
fast, simple and inexpensive way. 
 
 
(A)         (B)  
Figure 10. (A) Schematic representation of dendritic polyglycerol (dPGS). (B) Comparison of fluorescence images in 
false colors (normalized to a fluorescence reference cube) of a control rat and rats with collagen-induced rheumatoid 
arthritis (different clinical scores are indicated) after 10 min, 1 h and 24 h post injection of 6 (4 mg/kg b.w.). One 
representative example of at least n = 5. Copyright 2012, American Chemical Society. [80] 
 
4. REFERENCIAS 
[1]. Quadir MA, Calderón M, Haag R, Dendritic 
Polymers in Oncology: Facts, Features, and 
Applications, in Cancer Drug Delivery, W.-V. 
Books, Editor. 2011. 513-553. 
[2]. Haag R, Vögtle F, Angew. Chem., Int. Ed. Engl. 
2004; 43: 272-273. 
[3]. Fréchet JMJ, Tomalia DA, Dendrimers and Other 
Dendritic Polymers. 2001, Weinheim, Germany: 
Wiley-VCH Verlag GmbH & Co. KGaA. 
[4]. Huang B, Tomalia DA, J. Lumin. 2005; 111: 215-
223. 
[5]. Huang B, Tomalia DA, Inorg. Chim. Acta 2006; 
359: 1961-1966. 
[6]. Astruc D, Boisselier E, Ornelas Ct, Chemical 
Reviews 2010; 110: 1857-1959. 
[7]. Newkome GR, Shreiner C, Chemical Reviews 2010; 
110: 6338-6442. 
[8]. Mintzer MA, Grinstaff MW, Chemical Society 
Reviews 2011; 40: 173-190. 
[9]. Caminade A-M, Turrin C-O, Laurent R, Ouali A, 
Delavaux-Nicot B, Dendrimers: Towards Catalytic, 
Material and Biomedical Uses, ed. Wiley. 2011: 
Wiley. 
[10]. Buhleier E, Wehner W, Vögtle F, Synthesis 1978; 
78: 155-158. 
[11]. Zeng F, Zimmermann S, Chem. Rev. 1997; 97: 
1681-1712. 
[12]. Fischer M, Vögtle F, Angew. Chem. 1999; 111: 
934-955. 
[13]. Stiriba S, Frey H, Haag R, Angew. Chem., Int. Ed. 
Engl. 2002; 41: 1329-1334. 
[14]. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, 
Martin S, Roeck J, Ryder J, Smith P, Polym. J. 
1985; 17: 117-132. 
[15]. Wyszogrodzka M, Doctoral Thesis, Freie 
Universität Berlin, Germany 2008;  
[16]. Newkome GR, Yao Z, Baker GR, Gupta VK, The 
Journal of Organic Chemistry 1985; 50: 2003-2004. 
[17]. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, 
Martin S, Roeck J, Ryder J, Smith P, Polymer 
Journal 1985; 17: 117-132. 
[18]. Hawker CJ, Frechet JMJ, J. Am. Chem. Soc 1990; 
112: 7638. 
[19]. Rajca A, The Journal of Organic Chemistry 1991; 
56: 2557-2563. 
[20]. Wooley KL, Hawker CJ, Frechet JMJ, Journal of 
the American Chemical Society 1991; 113: 4252-
4261. 
[21]. Bosman A, Janssen H, Meijer E, Chem. Rev. 1999; 
 Artículo Invitado 
www.rlmm.org 
 
©2013 Universidad Simón Bolívar 13 Rev. LatinAm. Metal. Mat. 2013; 33 (1): 2-14 
 
99: 1665-1688. 
[22]. Tomalia D, Majoros I, Supramolecular Polymers, 
A.C. (Ed.). Editor. 2009, Marcel Dekker: New 
York. 359-435. 
[23]. Calderon M, Welker P, Licha K, Graeser R, Kratz F, 
Haag R, J. Control Release 2010; 148: e24-5. 
[24]. Yan D, Gao C, Frey H, Hyperbranched Polymers: 
Synthesis, Properties, and Applications 2011: John 
Wiley & Sons, Inc. 
[25]. Martinelli M, Calderón M, Rodríguez E, Freire J, 
Strumia M, Eur. Polym. J. 2007; 43: 1978-1985. 
[26]. Frauenrath H, Prog. Polym. Sci. 2005; 30: 325-384. 
[27]. Martinelli M, Calderón M, I. CA, Strumia M, React. 
Funct. Polym. 2007; 67: 1018-1026. 
[28]. Paez JI, Froimowicz P, Baruzzi AM, Strumia MC, 
Brunetti V, Electrochemical Comm. 2008; 10: 541-
545. 
[29]. Calderon M, Monzón L, Martinelli M, Juarez A, 
Strumia M, Yudi L, Langmuir 2008; 24: 6343-6350. 
[30]. Calderón M, M.Velasco, Strumia M, Lorenzo A, 
Müller A, M. Rojas, Sáez. A, J. Colloid Interface 
Sci. 2009; 336: 462-469. 
[31]. Aldana A, Martinelli M, Strumia M, Macromol. 
Symp. 2010; 298: 99-107. 
[32]. Cuggino JC, Calderón M, Alvarez CI, Strumia MC, 
Silva KN, Penott-Chang EK, Müller AJ, J. Colloid 
Interface Sci. 2011; 357: 147-156. 
[33]. Paez JI, Martinelli M, Brunetti V, Strumia MC, 
Polymers 2012; 4: 355-395. 
[34]. Cuggino JC, Calderón M, Alvarez CI, Strumia MC, 
Silva KN, Penott-Chang EK, Müller AJ, Journal of 
Colloid and Interface Science 2011; 357: 147-156. 
[35]. Calderón M, Velasco MI, Strumia MC, Lorenzo 
AT, Müller AJ, Rojas MR, Sáez AE, Journal of 
Colloid and Interface Science 2009; 336: 462-469. 
[36]. Suzuki M, Ii A, Saegusa T, Macromolecules 1992; 
25: 7071-7072. 
[37]. Calderón M, Quadir MA, Sharma SK, Haag R, 
Advanced Materials 2010; 22: 190-218. 
[38]. Sunder A, Hanselmann R, Frey H, Mülhaupt R, 
Macromolecules 1999; 32: 4240-4246. 
[39]. Sunder A, Mulhaupt R, DE Patent 19947631 A1, 
1998. PCT Int. Appl. 2000  
[40]. Kim YHJ, Polym. Sci. Polym. Chem. 1998; 36: 
1685. 
[41]. Voit BI, Acta Polym. 1995; 46: 87. 
[42]. Frechet JM, Henmi M, Gitsov I, Aoshima S, Leduc 
MR, Grubbs RB, Science 1995; 269: 1080-1083. 
[43]. Hawker CJ, Fréchet JMJ, Grubbs RB, Dao JJ, J. 
Am. Chem. Soc. 1995; 117: 10763. 
[44]. Frey H, Haag R, J. Biotechnol. 2002; 90: 257-67. 
[45]. Hanselmann R, Hölter D, Frey H, Macromolecules 
1998; 31: 3790. 
[46]. Carlmark A, Hawker C, Hult A, Malkoch M, Chem. 
Soc. Rev. 2009; 38: 352-362. 
[47]. Newkome GR, Moorefield CN, Vögtle F, 
Dendrimer Molecules: Concepts, Syntheses, 
Applications ed. W.-V.V.G.C. KGaA. 2002, 
Weinheim, Germany. 
[48]. Vögtle F, Richardt G, Werner N, Dendrimer 
Chemistry: Concepts, Syntheses, Properties, 
Applications. 2009, Weinheim, Germany: WILEY-
VCH Verlag GmbH & Co. KGaA. 
[49]. Gillies ER, Frechet JM, Drug Discov. Today 2005; 
10: 35-43. 
[50]. Haensler J, Szoka FC, Jr., Bioconjug. Chem. 1993; 
4: 372-9. 
[51]. Newkome GR, Moorefield CN, Baker GR, Saunders 
MJ, Grossman SH, Angew. Chem. Int. Ed. Engl. 
1991; 30: 1178-1180. 
[52]. Jansen JF, de Brabander-van den Berg EM, Meijer 
EW, Science 1994; 266: 1226-1229. 
[53]. Quadir MA, Haag R, J. Control Release 2012; 161, 
484-495.  
[54]. Xu S, Luo Y, Graeser R, Warnecke A, Kratz F, 
Hauff P, Licha K, Haag R, Bioorg. Med. Chem. 
Lett. 2009; 19: 1030-1034. 
[55]. Xu S, Luo Y, Haag R, Macromol. Biosci. 2007; 7: 
968-974. 
[56]. Xu S, Krämer M, Haag R, Journal of Drug 
Targeting 2006; 14: 367-374. 
[57]. Krämer M, Stumbé J-F, Türk H, Krause S, Komp A, 
Delineau L, Prokhorova S, Kautz H, Haag R, 
Angew. Chem., Int. Ed. Engl. 2002; 41: 4252-4256. 
[58]. Radowski MR, Shukla A, von Berlepsch H, 
Böttcher C, Pickaert G, Rehage H, Haag R, Angew. 
Chem., Int. Ed. Engl. 2007; 46: 1265-1269. 
[59]. Malik N, Evagorou EG, Duncan R, Anti-Cancer 
Drugs 1999; 10: 767-776. 
[60]. Gillies ER, Fréchet JMJ, Drug Discov. Today 2005; 
10: 35-43. 
[61]. Kratz F, Müller IA, Ryppa C, Warnecke A, 
ChemMedChem 2008; 3: 20-53. 
[62]. Haag R, Kratz F, Angew. Chem., Int. Ed. Engl. 
2006; 45: 1198-1215. 
[63]. Menjoge AR, Kannan RM, Tomalia DA, Drug 
Discovery Today 2010; 15: 171-185. 
[64]. Reichert S, Calderón M, Licha K, Haag R, 
Multivalent Dendritic Architectures in Theranostics, 
in Multifunctional Nanoparticles for Medical 
Applications - Imaging, Targeting, and Drug 
 Artículo Invitado 
www.rlmm.org 
 
©2013 Universidad Simón Bolívar 14 Rev. LatinAm. Metal. Mat. 2013; 33 (1): 2-14 
 
Delivery R. Prud'homme and S. Svenson, Editors. 
2012, Springer series: Nanostructure Science and 
Technology. 
[65]. Hamoudeh M, Kamleh MA, Diab R, Fessi H, Adv. 
Drug Delivery Rev. 2008; 60: 1329-1346. 
[66]. Zhou M, Ghosh I, Peptide Science 2007; 88: 325-
339. 
[67]. Wei A, Leonov AP, Wei Q, Gold Nanorods: 
Multifunctional Agents for Cancer Imaging and 
Therapy Cancer Nanotechnology, S.R. Grobmyer 
and B.M. Moudgil, Editors. 2010, Humana Press. 
119-130. 
[68]. Shen M, Shi X, Nanoscale 2010; 2: 1596-1610. 
[69]. Licha K, Schirner M, Emerging Optical Imaging 
Technologies: Contrast Agents, in In Translational 
Multimodality Optical Imaging, A. F.S. and I. X., 
Editors. 2008, Artech House Boston. 327-337. 
[70]. L. Villaraza AJ, Bumb A, Brechbiel MW, Chemical 
Reviews 2010; 110: 2921-2959. 
[71]. Kobayashi H, Sato N, Kawamoto S, Saga T, Hiraga 
A, Haque TL, Ishimori T, Konishi J, Togashi K, 
Brechbiel MW, Bioconjugate Chemistry 2000; 12: 
100-107. 
[72]. Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga 
A, Konishi J, Togashi K, Brechbiel MW, J. Magn. 
Reson. Imaging 2001; 14: 705-713. 
[73]. Louie A, Chemical Reviews 2010; 110: 3146-3195. 
[74]. Wiener EC, Konda S, Shadron A, Brechbiel M, 
Gansow O, Invest. Radiol. 1997; 32: 748-754. 
[75]. Barreto JA, O’Malley W, Kubeil M, Graham B, 
Stephan H, Spiccia L, Adv. Mater. 2011; 23: H18-
H40. 
[76]. Amir RJ, Pessah N, Shamis M, Shabat D, Angew. 
Chem. Int. Ed. Engl. 2003; 42: 4494-9. 
[77]. Türk H, Haag R, Alban S, Bioconjugate Chemistry 
2003; 15: 162-167. 
[78]. Dernedde J, Rausch A, Weinhart M, Enders S, 
Tauber R, Licha K, Schirner M, Zügel U, von Bonin 
A, Haag R, Proc. Natl. Acad. Sci. U. S. A 2010; 
107: 19679-19684. 
[79]. Khandare J, Calderon M, Dagia NM, Haag R, 
Chem. Soc. Rev. 2012, 41, 2824-2848.  
[80]. Licha K, Welker P, Weinhart M, Wegner N, Kern S, 
Reichert S, Gemeinhardt I, Weissbach C, Ebert B, 
Haag R, Schirner M, Bioconjugate Chemistry 2011; 
22: 2453-2460. 
 
 
 
Miriam Cristina Strumia, Titular Professor and Principal Investigator of CONICET, Argentina.  
 
Dr. Miriam Strumia received her doctoral degree in Organic Chemistry in 1982 from the Universidad Nacional de 
Córdoba, Argentina under the supervision of Prof. Hector Bertorello. She was a postdoctoral research fellow with Prof. 
George Newkome in Dendritic Chemistry at the University of South Florida, United State (1995). Prof. Strumia has 
directed nine doctoral and two masters thesis and has 90 scientific international publications in the field of polymer and 
dendritic chemistry. At present she is a full Professor at the Department of Organic Chemistry, Facultad de Ciencias 
Químicas of the Universidad Nacional de Córdoba (Argentina) and a Principal Investigator from Consejo Nacional de 
Investigación en Ciencia y Tecnología (CONICET). Her main research interest are the synthesis and chemical 
modification to obtain new polyfunctional materials or nanomaterials, with specific application properties as biomedical 
materials, active and intelligent packaging, electrochemical sensors, and macro-porous supports for their uses in 
chromatography techniques.  
 
 
Marcelo Calderón, Junior Group Leader at the Freie Universität Berlin, Germany. 
 
Dr. Marcelo Calderón received his Ph.D. in organic chemistry in 2007 from the National University of Córdoba, 
Argentina, under the supervision of Prof. Miriam Strumia. His research topic dealt with the preparation of amphiphilic 
polymers by dendronization. In 2007 he joined the Research Group of Prof. Rainer Haag at the Freie Universitat Berlin for 
his postdoctoral work, where he pursued the development of polymer-drug conjugates for the passive targeted delivery of 
drugs. His current research as a Junior Group Leader at the Freie Universitat Berlin is dedicated to the development of new 
delivery systems based on multifunctional polymer-drug conjugates, self-assembling amphiphiles for the controlled 
delivery of bioactives, and new diagnostic technologies for theranostic approaches. 
 
 
 
